While progerin clearance mediated by selinexor may be sufficient to improve the physiology of HGPS cells, we believe that the nuclear accumulation of key proteins due to CRM1 inhibition, contributes to the therapeutic effect of Selinexor for the following reasons. The gene discussed is XPO1; the disease is Hutchinson-Gilford progeria syndrome.